pubmed-article:16864486 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:16864486 | lifeskim:mentions | umls-concept:C0029882 | lld:lifeskim |
pubmed-article:16864486 | lifeskim:mentions | umls-concept:C0029883 | lld:lifeskim |
pubmed-article:16864486 | lifeskim:mentions | umls-concept:C0011777 | lld:lifeskim |
pubmed-article:16864486 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
pubmed-article:16864486 | lifeskim:mentions | umls-concept:C0140594 | lld:lifeskim |
pubmed-article:16864486 | lifeskim:mentions | umls-concept:C0332237 | lld:lifeskim |
pubmed-article:16864486 | lifeskim:mentions | umls-concept:C1522168 | lld:lifeskim |
pubmed-article:16864486 | lifeskim:mentions | umls-concept:C1517004 | lld:lifeskim |
pubmed-article:16864486 | pubmed:issue | 9 | lld:pubmed |
pubmed-article:16864486 | pubmed:dateCreated | 2006-7-25 | lld:pubmed |
pubmed-article:16864486 | pubmed:abstractText | The lipopolysaccharide (LPS)-induced chinchilla otitis media (OM) model was proven useful in screening anti-inflammatory agents for topical use. Both 1% rimexolone and 1% dexamethasone are effective in reducing the volume of middle ear effusion and mucosal thickness compared with control groups. Topical corticosteroid therapy was efficacious in reducing middle ear mucosal inflammation. | lld:pubmed |
pubmed-article:16864486 | pubmed:language | eng | lld:pubmed |
pubmed-article:16864486 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16864486 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:16864486 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16864486 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16864486 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16864486 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16864486 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:16864486 | pubmed:month | Sep | lld:pubmed |
pubmed-article:16864486 | pubmed:issn | 0001-6489 | lld:pubmed |
pubmed-article:16864486 | pubmed:author | pubmed-author:ParkSeong... | lld:pubmed |
pubmed-article:16864486 | pubmed:author | pubmed-author:WallG... | lld:pubmed |
pubmed-article:16864486 | pubmed:author | pubmed-author:LeeChoong-Won... | lld:pubmed |
pubmed-article:16864486 | pubmed:author | pubmed-author:FloreaAndrewA | lld:pubmed |
pubmed-article:16864486 | pubmed:author | pubmed-author:ZwartJon EJE | lld:pubmed |
pubmed-article:16864486 | pubmed:author | pubmed-author:DepewAronA | lld:pubmed |
pubmed-article:16864486 | pubmed:author | pubmed-author:InmanJaredJ | lld:pubmed |
pubmed-article:16864486 | pubmed:author | pubmed-author:WarehamRachel... | lld:pubmed |
pubmed-article:16864486 | pubmed:author | pubmed-author:JohnsonKaalan... | lld:pubmed |
pubmed-article:16864486 | pubmed:author | pubmed-author:JohnEarnestE | lld:pubmed |
pubmed-article:16864486 | pubmed:author | pubmed-author:JungTimothyT | lld:pubmed |
pubmed-article:16864486 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:16864486 | pubmed:volume | 126 | lld:pubmed |
pubmed-article:16864486 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:16864486 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:16864486 | pubmed:pagination | 910-5 | lld:pubmed |
pubmed-article:16864486 | pubmed:meshHeading | pubmed-meshheading:16864486... | lld:pubmed |
pubmed-article:16864486 | pubmed:meshHeading | pubmed-meshheading:16864486... | lld:pubmed |
pubmed-article:16864486 | pubmed:meshHeading | pubmed-meshheading:16864486... | lld:pubmed |
pubmed-article:16864486 | pubmed:meshHeading | pubmed-meshheading:16864486... | lld:pubmed |
pubmed-article:16864486 | pubmed:meshHeading | pubmed-meshheading:16864486... | lld:pubmed |
pubmed-article:16864486 | pubmed:meshHeading | pubmed-meshheading:16864486... | lld:pubmed |
pubmed-article:16864486 | pubmed:meshHeading | pubmed-meshheading:16864486... | lld:pubmed |
pubmed-article:16864486 | pubmed:meshHeading | pubmed-meshheading:16864486... | lld:pubmed |
pubmed-article:16864486 | pubmed:meshHeading | pubmed-meshheading:16864486... | lld:pubmed |
pubmed-article:16864486 | pubmed:meshHeading | pubmed-meshheading:16864486... | lld:pubmed |
pubmed-article:16864486 | pubmed:meshHeading | pubmed-meshheading:16864486... | lld:pubmed |
pubmed-article:16864486 | pubmed:meshHeading | pubmed-meshheading:16864486... | lld:pubmed |
pubmed-article:16864486 | pubmed:meshHeading | pubmed-meshheading:16864486... | lld:pubmed |
pubmed-article:16864486 | pubmed:meshHeading | pubmed-meshheading:16864486... | lld:pubmed |
pubmed-article:16864486 | pubmed:meshHeading | pubmed-meshheading:16864486... | lld:pubmed |
pubmed-article:16864486 | pubmed:year | 2006 | lld:pubmed |
pubmed-article:16864486 | pubmed:articleTitle | Effect of topical dexamethasone versus rimexolone on middle ear inflammation in experimental otitis media with effusion. | lld:pubmed |
pubmed-article:16864486 | pubmed:affiliation | Division of Otolaryngology-Head & Neck Surgery, Loma Linda University School of Medicine, Loma Linda, CA, USA. | lld:pubmed |
pubmed-article:16864486 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:16864486 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |